Brr Op Co, LLC Gilead Sciences, Inc. Transaction History

Brr Op Co, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1.02 Million - $1.17 Million	-18,064 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $96,876 - $121,804	1,560 Added 9.45%	18,064 $1.14 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $41,667 - $48,384	-576 Reduced 3.37%	16,504 $1.27 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $34,195 - $43,800	-546 Reduced 3.1%	17,080 $1.28 Million
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $124,164 - $136,576	2,015 Added 12.91%	17,626 $1.15 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $78,137 - $86,250	1,250 Added 8.7%	15,611 $989,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $679,827 - $762,347	10,988 Added 325.76%	14,361 $970,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $210,913 - $236,278	3,373 New	3,373 $219,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

Stay updated on Brr Op Co, LLC with notifications on news.